Searched for
ATUL SOBTI CHAIRMAN
BHEL declares 91% dividend for FY18PAT for the year jumped 63 per cent to Rs 807 crore, against Rs 496 crore in the previous fiscal.
BHEL Q1 net profit doubles to Rs 156 crore; Co meets Street estimatesMargins for the period under review came in at 4.9 per cent, up 120 basis points.
BHEL pays 40% interim dividendAccelerating its growth momentum, BHEL has reported a surge in profitability up to the third quarter of 2017-18.
BHEL Q3 profit up 64% at Rs 153 croreThe company's standalone net profit was Rs 93.54 crore in the same quarter last fiscal.
BHEL ties up with Kawasaki to make steel metro coachesThe agreement covers establishing state-of-the-art design, engineering and manufacturing facilities at BHEL, India, using Japanese technolo...
BHEL not worried about CEA draft reportBHEL was also targeting stranded power projects and said recently one project worth Rs 8,000 crore was started.
Bhel to reduce dependency on thermal power plant marketBhel has invested Rs 300 crore to enhance its solar photo voltaic cell making capability to 225 MW as part of its plan to shed thermal busi...
14 CEOs to meet Nirmala Sitharaman before India-US strategic dialogueThe Commercial Track of the dialogue will be led by Sitharaman from India side and Penny Pritzker from the US.
Atul Sobti to be Bharat Heavy Electricals Ltd's next CMDBharat Heavy Electricals Ltd today said Atul Sobti will be its next chairman and managing director and will take charge on or after January...
- Arun Sawhney to replace Atul Sobti as Ranbaxy CEO
Sobti’s exit comes at a time, when the company seems to have seen the worst of its regulatory problems in the US which has dragged its reve...
- Atul Sobti to step down as Ranbaxy CEO & MD?
Arun Sawhney, president global pharmaceutical business is seen as a contendor to take over Sobti's position. Sobti was more of an interim C...
- Ranbaxy to step up head count, launch new drugs
Ranbaxy Laboratories, hit by charges of sub-standard drugs, is raising sales staff by a third and launching scores of new drugs that would ...
- Ranbaxy cuts pay package to one-third for new chief
The country's top drugmaker, Ranbaxy, has proposed an annual pay package of Rs 6 crore for its new CEO and MD Atul Sobti, but his remunerat...
- Ranbaxy misses May deadline to supply raw materials to Astrazeneca
Supplies to Astrazeneca which could have potentially brought revenues of $40 million this year (May-December 2009) has been delayed by 2-3 ...
- Ranbaxy shareholders gain Rs 1,900 cr in a single day
Investors in Ranbaxy Laboratories got richer by over Rs 1,900 crore in a single day as the scrip surged by a little over 20 per cent on the...
- Ranbaxy Laboratories rejigs board, Malvinder is chairman
Ranbaxy Laboratories and its new owner Japan’s Daiichi Sankyo on Friday reconstituted a new 10-member board.
- Ranbaxy announces reconstitution of Board of Director
Ranbaxy Laboratories and Japanese drug major Daiichi Sankyo today jointly announced the reconstitution of the Gurgaon-based company's Board...